Savvy Update 11/20/23: Liver-Targetted Insulin/Dr. Jeremy Pettus, Relieving Stress on Beta Cells, UHC Sued re Algorithm to Block Coverage, Dexcom Defeats Abbott in UK, Thanksgiving CARBS
Could Liver-Targeted Insulin Be the Future of Type 1 Diabetes Care? by April Hopcroft for diaTribe.org, 13 November 2023. Dr. Jeremy Pettus, associate professor of medicine at UC San Diego Health who also has type 1 diabetes, is leading research on insulin that...
Savvy Updates 11/13/23: Diamyd Medical/DiaUnion Trial for Precision Medicine, Cost of Diabetes Skyrockets, OptumRx Moves Insulin to Preferred Status, FDA Warns Against SugarMD Supplement, Human Insulin Storage, Interview with Dr. Mike Natter, Broccoli Benefits, Food for Thought with Gina Pillini
Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial posted on PRNewsWire.com, 7 November 2023. Diamyd Medical has entered into a collaboration agreement with DiaUnion, a center of excellence in type 1 diabetes, to...
Savvy Updates, 11/6/23: EASD 2023 Highlights, Dario & iPhone, Tandem’s Mobi Pump, Sibionics Wins CE Mark, Join Trial for Vertex VX-264, Food for Thought about INSULIN
Diabetes Technology in the Spotlight: 10 EASD Highlights was posted by Diabetotech.com, 21 October 2023. Listed below are the top ten highlights from this year’s EASD Congress from Dr. Inge Boxelaer of Diabetotech, referencing the comprehensive reporting...
Savvy Updates, 10/30/23: Omnipod 5 Cleared for iPhone, Tandem Mobi Listed as One of Top Inventions of 2023, Eye Implants Treats T1D, Dexcom Stock Soars, ExpressScripts Sues for Pricing Fixing, Diagnose Diabetes by Phone/Voice, Halloween & T1D
Insulet celebrates Apple season with FDA clearance for Omnipod 5 iPhone app by Andrea Park for FierceBioTech.com, 23 October 2023. Insulet has earned FDA clearance for the iPhone version of an app allowing users to control their Omnipod 5 insulin pumps from their own...Gone Fishin’ = had surgery, taking the week off!
I’ll be back next week … nothing much shaking this week. Wishing you all a great week and many thanks … joanne
Savvy Updates 10/16/23: Insulet Wins Prelim Injunction v. EOFlow, T1D & Emotional Distress, Best Buy Sells CGMs, Treating CKD in T1D, Vertex New Data, Biomea Fusion’s Cell Therapy Application Cleared, 6th Basic Flavor – Umami, NPs Sue for “Dr.” Title, Avg Body Temp Lower Than 98.6
Insulet wins preliminary injunction against EOFlow in patent suit by Susan Kelly for MedTechDive.com, 9 October 2023. A federal judge has blocked EOFlow, a company that Medtronic plans to acquire, from selling its insulin patch pump. The U.S. District Court for...
Savvy Updates 10/9/23: Insulin Resistance, Ozempic Warning, Exec Changes in D Companies, HbA1c Cutoffs Need To Be Lower in Premenopausal Women, Hybrid Closed Loop System Safe for T1D in Pregnancy, Mfr Co-Pay Card Accumulators Overturned
What Is Insulin Resistance and How Do You Know if You Have It? by Knvul Sheikh for NYTimes.com, 3 October 2023. Insulin is a hormone secreted by the pancreas that is crucial for converting food into energy, or storing that energy for later. When your blood...
Savvy Looping: News & Tips for DIY looping T1Ds
I started the Facebook group, Loop and Learn (originally So Cal Loopers for those using DIY Loop in southern California) about 5 years ago. It is now one of the larger Facebook groups about how to build and then, more importantly, how to best manage your Type 1...
Savvy Updates, 10/2/23: Senseonics Completes 365-Day Study, SiBionics CGM & GiveAway, Abvance’s Coformulation of Insulin & Glucagon, Period Cravings & Insulin Sensitivies, Ozempic Reduces Insulin Needs in T1Ds, CVS Caremark Sued By Independent Pharmacy for Antitrust Violations
Senseonics completes 365-day CGM study cohort by Sean Whooley for DrugDeliveryBusiness.com, 26 September 2023. Senseonics announced that it completed its ENHANCE pivotal clinical study adult cohort for its 365-day Eversense CGM. The study evaluates the year-long...
More Diabetes Blogs